Skip to main content
SpringerLink
Log in

Some sulfonylureas increase risk of MACE in patients with T2DM

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Wang MT, et al. Association Between Specificity of Sulfonylureas to Cardiac Mitochondrial KATP Channels and the Risk of Major Adverse Cardiovascular Events in Type 2 Diabetes. Diabetes Care : 16 Mar 2022. Available from: URL: http://doi.org/10.2337/dc21-1779

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Some sulfonylureas increase risk of MACE in patients with T2DM. Reactions Weekly 1899, 11 (2022). https://doi.org/10.1007/s40278-022-11985-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-11985-x

Search

Navigation